News Home

Citizens plans $850mn cat bonds as it looks to double reinsurance limit

The Floridian insurer aims to renew just over a third of its private reinsurance placement in cat bond cover.

FedNat to raise $43mn in rights issue as Uri claims bite

Texas winter storm losses to spill over FedNat reinsurance retention.

Climate change impact on Storm Uri unclear: experts

Ageing infrastructure is a more obvious culprit for the high insured losses, BMS’s Andrew Siffert said.

American Capital Assurance downgraded to CCC+ from A- by AM Best

AmCap was stripped of its Demotech rating altogether after deciding to “no longer participate” in the rating process.

• Former CatCo CUO Moore joins Lockton Re retro team
• Citizens to buy $2.6bn in reinsurance
• Amwins scopes personal and commercial targets for Integral partnership
• CoStar withdraws $7bn-plus bid for CoreLogic
• PartnerRe promotes Bishop to lead aggregate cat risk and ILW teams
• New Zealand hit by trio of earthquakes but little damage emerges

Opinion

Latent risk – The cat market’s inconvenient truth

When there is nothing average about cat losses, why benchmark to the mean?

ILS market enjoying spoils of post-Covid interest

Swiss Re's fund launch is a bigger ILS pivot than it may seem

Analysis

Armour ILS legacy funds fell to major 2019 loss before wind-down

The funds made a $93.9mn loss in 2019, ahead of a leadership changeover at legacy adviser Armour.

Texas Big Freeze: Why are the numbers so far apart?

As some in the market believe the winter claims will remain notably below $20bn, there are multiple factors creating challenges in assessing the event.

Evolving commutation practices tested by Covid and final Irma tie-up

While uncertainty over Covid may limit early commutations, isolated deals may have been struck, as 2017 contracts in some cases remain open.

Bilateral deals support sidecar growth at 1.1

One estimate suggested around $2bn of new capacity in private deals.

Supplements

(Re)Connect 2020 - ILS Roundtable

Covid-19 may have been the biggest talking point in the (re)insurance markets this year but arguably, the pandemic is being overtaken by several other factors – ILS market dynamics amongst them.

Investor Guide to ILS: H2 2020

Covid-19 and ILS strategies: locking down diversification benefits.